Clinical Trial Update: Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating desmopressin (DDAVP) in patients with colorectal cancer and rectal bleeding has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Bleeding

Drugs mentioned

• Desmopressin (DDAVP) (Desmopressin)

Snippet

Sponsor: Laboratorio Elea Phoenix S.A. | Conditions: Colorectal Cancer, Rectal Bleeding | Phase 2 | Status: COMPLETED